Total Payments
$7,137
2020 Payments
$1,575
Companies
6
Transactions
18
Medicare Patients
3,064
Medicare Billing
$873,185
Payment Breakdown by Category
Consulting$4,075 (57.1%)
Travel$2,302 (32.3%)
Food & Beverage$759.66 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,075 | 2 | 57.1% |
| Travel and Lodging | $2,302 | 8 | 32.3% |
| Food and Beverage | $759.66 | 8 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $3,736 | 8 | $0 (2017) |
| Cardinal Health 108 LLC | $1,575 | 1 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,455 | 6 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $205.52 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $115.25 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $49.74 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $1,575 | 1 | Cardinal Health 108 LLC ($1,575) |
| 2019 | $1,825 | 9 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,455) |
| 2017 | $3,736 | 8 | Allergan Inc. ($3,736) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2020 | Cardinal Health 108 LLC | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 09/24/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Travel and Lodging | Cash or cash equivalent | $242.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/10/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS PC (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Travel and Lodging | Cash or cash equivalent | $132.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Travel and Lodging | Cash or cash equivalent | $98.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS (Device) | Travel and Lodging | Cash or cash equivalent | $925.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/31/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/27/2019 | Carl Zeiss Meditec, Inc. | Clarus 700 (Device) | Food and Beverage | In-kind items and services | $205.52 | General |
| Category: Fundus Camera | ||||||
| 07/27/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $49.74 | General |
| 06/12/2017 | Allergan Inc. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: RETINA | ||||||
| 06/12/2017 | Allergan Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $95.50 | General |
| Category: RETINA | ||||||
| 06/12/2017 | Allergan Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $8.00 | General |
| Category: RETINA | ||||||
| 05/20/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $123.53 | General |
| Category: RETINA | ||||||
| 05/20/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $113.55 | General |
| Category: RETINA | ||||||
| 05/20/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $96.53 | General |
| Category: RETINA | ||||||
| 05/19/2017 | Allergan Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $452.56 | General |
| Category: RETINA | ||||||
| 05/19/2017 | Allergan Inc. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $346.61 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 11 | 1,020 | 1,539 | $338,515 | $150,961 |
| 2020 | 20 | 2,044 | 5,470 | $1.6M | $722,224 |
Total Patients
3,064
Total Services
7,009
Medicare Billing
$873,185
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 39 | 104 | $104,000 | $73,040 | 70.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 32 | 188 | $82,720 | $47,849 | 57.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 314 | 491 | $41,735 | $8,208 | 19.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 224 | 250 | $22,500 | $7,784 | 34.6% |
| 67028 | Injection of drug into eye | Office | 2021 | 84 | 129 | $51,600 | $7,752 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 26 | $3,380 | $1,714 | 50.7% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 164 | 180 | $15,300 | $1,402 | 9.2% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 70 | 86 | $7,310 | $982.45 | 13.4% |
| 67515 | Injection of medication or substance into membrane covering eyeball | Office | 2021 | 36 | 50 | $7,500 | $969.97 | 12.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 15 | 18 | $1,620 | $860.19 | 53.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 17 | $850.00 | $400.00 | 47.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 86 | 376 | $376,000 | $278,121 | 74.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2020 | 62 | 594 | $259,600 | $157,125 | 60.5% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2020 | 19 | 354 | $123,900 | $82,580 | 66.7% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 463 | 1,783 | $151,555 | $45,119 | 29.8% |
| 67041 | Removal of membrane from the retina | Facility | 2020 | 46 | 47 | $225,600 | $41,512 | 18.4% |
| 67028 | Injection of drug into eye | Office | 2020 | 148 | 473 | $189,200 | $33,147 | 17.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 334 | 547 | $49,230 | $27,905 | 56.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 157 | 251 | $22,590 | $11,995 | 53.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 79 | 90 | $11,700 | $8,034 | 68.7% |
| 66820 | Removal of recurring cataract in lens capsule | Facility | 2020 | 39 | 40 | $40,000 | $6,487 | 16.2% |
| 67515 | Injection of medication or substance into membrane covering eyeball | Office | 2020 | 86 | 189 | $28,800 | $5,217 | 18.1% |
| 65875 | Removal of scar tissue in eye | Facility | 2020 | 21 | 21 | $21,000 | $5,102 | 24.3% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2020 | 115 | 209 | $17,765 | $3,992 | 22.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 33 | 69 | $6,210 | $3,838 | 61.8% |
About Dr. Nabil Jabbour, M.D
Dr. Nabil Jabbour, M.D is a Ophthalmology healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891770525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nabil Jabbour, M.D has received a total of $7,137 in payments from pharmaceutical and medical device companies, with $1,575 received in 2020. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($4,075).
As a Medicare-enrolled provider, Jabbour has provided services to 3,064 Medicare beneficiaries, totaling 7,009 services with total Medicare billing of $873,185. Data is available for 2 years (2020–2021), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Morgantown, WV
- Active Since 12/15/2005
- Last Updated 04/11/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891770525
Products in Payments
- OZURDEX (Drug) $3,736
- STELLARIS (Device) $1,430
- Clarus 700 (Device) $205.52
- EYLEA (Biological) $115.25
- STELLARIS PC (Device) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Morgantown
Dr. Anthony Realini, M.d, M.D
Ophthalmology — Payments: $442,002
Ophthalmology $442,002
Dr. John Nguyen, Md, MD
Ophthalmology — Payments: $100,920
Ophthalmology $100,920
Dr. Mark Mayle, M.d, M.D
Ophthalmology — Payments: $7,793
Ophthalmology $7,793
Brian Mcmillan
Ophthalmology — Payments: $7,451
Ophthalmology $7,451
Dr. Jennifer Sivak-Callcott, M.d, M.D
Ophthalmology — Payments: $7,224
Ophthalmology $7,224
Dr. Edgar Gamponia, M.d, M.D
Ophthalmology — Payments: $3,346
Ophthalmology $3,346